Article info

Download PDFPDF
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration

Authors

  1. Correspondence to Dr Ilse Krebs, Department of Ophthalmology, Rudolf Foundation Clinic, Teaching Hospital of the Medical University Vienna, Juchgasse 25, Vienna 1030, Austria; Ilse.Krebs{at}wienkav.at
View Full Text

Citation

Krebs I, Schmetterer L, Boltz A, et al
A randomised double-masked trial comparing the visual outcome after treatment with ranibizumab or bevacizumab in patients with neovascular age-related macular degeneration

Publication history

  • Received July 20, 2012
  • Revised November 8, 2012
  • Accepted November 26, 2012
  • First published January 3, 2013.
Online issue publication 
February 15, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.